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Abstract
Background: Retinoids are a class of compounds that are chemically related to vitamin A, which is an essential nutrient that
plays a key role in vision, cell growth and differentiation. In vivo, retinoids must bind with specific proteins to perform their
necessary functions. Plasma retinol-binding protein (RBP) and epididymal retinoic acid binding protein (ERABP) carry
retinoids in bodily fluids, while cellular retinol-binding proteins (CRBPs) and cellular retinoic acid-binding proteins (CRABPs)
carry retinoids within cells. Interestingly, although all of these transport proteins possess similar structures, the modes of
binding for the different retinoid ligands with their carrier proteins are different.
Methodology/Principal Findings: In this work, we analyzed the various retinoid transport mechanisms using structure and
sequence comparisons, binding site analyses and molecular dynamics simulations. Our results show that in the same family
of proteins and subcellular location, the orientation of a retinoid molecule within a binding protein is same, whereas when
different families of proteins are considered, the orientation of the bound retinoid is completely different. In addition, none
of the amino acid residues involved in ligand binding is conserved between the transport proteins. However, for each
specific binding protein, the amino acids involved in the ligand binding are conserved. The results of this study allow us to
propose a possible transport model for retinoids.
Conclusions/Significance: Our results reveal the differences in the binding modes between the different retinoid-binding
proteins.
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Introduction
Vitamin A is an essential nutrient that plays a key role in vision,
cell growth and differentiation, and embryonic development.
Vitamin A is ingested from dietary sources as a retinyl ester or
synthesized from b-carotene and is stored in the liver as a retinyl
ester until it is mobilized for delivery to various target tissues.
Retinol is one of the forms of vitamin A obtained from foods of
animal origin. Retinal (retinaldehyde), the aldehyde derived from
retinol, is essential for vision, while retinoic acid is essential for skin
health and bone growth. These chemical compounds are
collectively known as retinoids and possess the same structural
motif (i.e., all-trans double bonds) found in retinol. Structurally, all
retinoids possess a b-ionone ring and a polyunsaturated side chain
containing an alcohol, an aldehyde, a carboxylic acid group or an
ester group [1]. Because of their chemical instability and fairly low
solubility in aqueous media, retinoids must be bound by specific
proteins in bodily fluids and within cells. Plasma retinol-binding
protein (RBP) and epididymal retinoic acid binding protein
(ERABP) carry retinoids in bodily fluids, while cellular retinol-
binding proteins (CRBPs) and cellular retinoic acid-binding
proteins (CRABPs) carry retinoids within cells [2].
RBP, ERABP, CRBPs (CRBP I, II, III, and IV) and CRABPs
(CRABP I and CRABP II) belong to the lipocalins superfamily in
the Structural Classification of Proteins (SCOP) database [3].
Although they differ both in sequence and function, all members
of the lipocalins superfamily contain a six- or eight-stranded b-
barrel as part of their tertiary structure and a highly conservative
motif, the short conserved region (SCR), as part of their amino
acid sequence [4]. In the SCOP, RBP and ERABP belong to the
retinol-binding protein-like (RBP) family. CRBPs and CRABPs
belong to the fatty acid-binding protein-like (FABP) family. RBP is
the specific carrier for retinol (vitamin A alcohol) in the blood. It
delivers retinol from the liver stores to peripheral tissues. In
plasma, the RBP-retinol complex interacts with transthyretin,
which prevents it from being filtered out of the blood by the kidney
glomeruli. The basic structural framework of RBP consists of an
eight-stranded up-and-down b-barrel onto which a carboxy-
terminal a-helix is attached [5,6]. ERABP in the lumen of the
epididymis is required for sperm maturation and binds both all-
trans retinoic acid and 9-cis retinoic acid. Like all other lipocalins,
ERBP contains an eight-stranded up-and-down b-sheet core,
which twists into a barrel. One end of the barrel is closed off by
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chains from the amino terminus portion of the protein, which
wrap across the back side of the barrel [7]. As with other proteins
in the FABP family, CRBPs and CRABPs have an overall tertiary
structure comprised of 10 anti-parallel b-strands, which are
themselves formed from two five-stranded b-sheets arranged
approximately perpendicular to each other [8]. CRBP I, II, III
and IV are highly homologous proteins, but have distinct tissue
distributions and retinoid-binding properties. Among these
CRBPs, mammalian CRBP I and II are the best-characterized
members of the CRBP family and are known to bind all-trans
retinol and all-trans retinal with a high affinity but not all-trans
retinoic acid [2,7,9,10,11]. Cellular retinoic acid-binding proteins
may regulate the interactions between retinoic acids and their
nuclear receptors by regulating the concentration of retinoic acids
present [12,13].
In general, if two ligands are structurally similar, the orientation
and mode of binding for these ligands in related proteins is
typically conserved. That is, a majority of the ligand pairs occupy
the same space in the binding sites [14]. Interestingly, although
RBP, ERABP, CRBPs and CRABPs have homologous structural
motifs and overlapping ligand specificity, they have different
binding mechanisms. This demonstrates an important principle,
namely, that similar protein architectures can be used to bind
identical ligands via completely different ways. For example,
Kleywegt was the first to discover that ERABP and CRABP bind
retinoic acid with different orientations. However, they gave no
explanation regarding the evolutionary of the two binding modes
[13]. Although many researchers are interested in the different
mechanisms of retinoid transport [7,13,15], most studies focus on
comparisons within one family of proteins, such as comparisons of
RBP with ERABP and CRABP with CRBP. To date, there are no
exhaustive studies on the mechanisms of retinoid transport that
rely on structural analysis.
The aim of this study is to investigate the differences in the
various retinoid transport mechanisms. First, we compare the
structures of the transport proteins and the differences in their
sequences. Then, we analyze the conservation of the retinoid
binding residues in the transport proteins. Finally, we propose a
possible retinoid transport model and support the model with
evidence from molecular dynamics simulations. This study may be
useful in delineating the transport mechanism of retinoids.
Figure 1. Comparison of retinoid binding in their transport proteins. In the same protein family and subcellular location, retinol and retinoic
acid have the same binding orientation (A, B), while in different protein families and subcellular locations, the binding orientations of the ligands are
completely different (C, D). (a) In both of the extracellular proteins (RBP, ERABP), the b-ionone ring of the ligand is positioned in the center of the
barrel with the isoprene tail extending along the barrel axis pointing toward the solvent. (b) The orientation of the ligand is, therefore, opposite to
that in the corresponding intracellular retinoid-binding proteins (CRBPs and CRABPs). The red, blue, green and pink lines indicate RBP (PDB code:
1brp), ERABP (PDB code: 1epb), CRBP (PDB code: 1crb), and CRABP (PDB code: 1cbs) protein structures, respectively. The colors representing retinol
and retinoic acid correspond to different transport protein colors.
doi:10.1371/journal.pone.0036772.g001
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Retinoid transport proteins bind identical ligands via
different ways
As their names imply, RBP, ERABP, CRBPs and CRABPs bind
similar hydrophobic ligands, including retinol, retinal and retinoic
acid, in their interior. Structurally, these proteins belong to the
lipocalins superfamily according to the SCOP, which have either a
closed or open barrel structural framework consisting of eight to
ten anti-parallel b-strands. Meanwhile, all retinoids have both a b-
ionone ring and a polyunsaturated side chain containing an
alcohol, an aldehyde, and a carboxylic acid group or an ester
group. Although RBP, ERABP, CRBPs and CRABPs bind similar
ligands (RBP and CRBPs both bind retinol; ERABP and CRABPs
both bind retinoic acid), the protein-ligand binding patterns are
very different among them (Fig. 1). Proteins of the same family and
subcellular location have the same binding orientations. However,
when comparing different families of proteins and subcellular
locations, the binding orientations of retinoids are completely
different. In both of the extracellular retinoid-binding proteins
(RBP and ERABP), the b-ionone ring of the ligand is positioned in
the center of the barrel with the isoprene tail extending along the
barrel axis pointing toward the solvent. However, the orientation
of the ligand is opposite to that of the corresponding intracellular
proteins (CRBPs and CRABPs).
The difference of retinoid binding mechanisms among
transport proteins within the same family
In the RBP family, RBP and ERABP share a low sequence
similarity (21.9%), and display various structural differences
(Fig. 1A). In addition to the up-and-down b-barrel, RBP has only
one C-terminal a-helix, but ERABP has two. These differences are
presumably necessary to allow RBP to be specific for retinol, but
not retinoic acid. Structural comparison shows that none of the
amino acid residues that form the ligand-binding cavity in RBP is
conserved in ERABP. In RBP, retinol binds to a region that is
close to the surface of the protein. However, in ERABP, the
binding site is deeper in the barrel. The ligand specificity of
ERABP is greater than that of RBP. At the portion of the ligand
binding site that interacts with the polar tail of the ligand,
electrostatic interactions determine the binding specificity [7]. Our
dynamics simulations showed that the binding affinity (Table S1)
between ERABP and retinoic acid (binding energy:
2105.47 kcal/mol) is stronger than that between RBP and retinol
(binding energy: 286.83 kcal/mol) (p=1.83610
24).
In the FABP family, the sequence similarity between CRBP and
CRABP is 41% (Table S2). A comparison of their structures shows
that their b-sheets are highly superposed (Rmsd=1.5 A ˚) (Table
S3). However, in CRABP, the retinoic acid binds near the
entrance of the barrel, which is higher than for retinol (Fig. 1B). It
has been suggested that a trio of residues determine the binding
specificity of CRBPs and CRABPs for their ligands [16,17]. In
most FABPs and all CRABPs, three residues (Argl06, Arg126 and
Tyr128) that interact with the carboxylate of the bound fatty-acid
ligand are highly conserved. In CRBPs, the structurally equivalent
residues were altered to be Gln108, Gln128 and Phel30 [18].
These mutations may be necessary to allow RBP to be specific for
retinol but not retinoic acid. Thus the retinoid binding site differs
significantly between the two types of proteins. In addition, none
of the ligand-binding amino acids is conserved between CRBPs
and CRABPs (Fig. 1B).
Deciphering the sequence code for protein folding requires the
ability to determine which residues are essential for specifying a
given fold. Many residues in a protein confer functional capacities,
but others may mediate properties cruciality for the success of a
protein in its cellular environment (e.g., solubility, biosynthesis,
turn-over) [8]. We conclude that the striking structural homology
across many organisms, cell types, and ligand shapes is preserved
because of the common role of these proteins—to bind relatively
large retinoids that present highly hydrophobic surfaces.
The difference modes of retinol binding for RBP and
CRBPs
Despite binding the same ligand, retinol, the sequences of RBP
and CRBPs have a low sequence similarity (9.34%) (Table S2).
Moreover, structural alignment shows that significant structural
differences are apparent (Rmsd=4.4 A ˚) (Fig. 1C and Table S3).
There is no overlap in the secondary structures of RBP and
CRBPs. In addition to an inverted binding orientation of retinol,
the polyunsaturated side chain of retinol in cellular retinol-binding
proteins is deeper in the cavity (Fig. 1C).
The contacts between the cyclohexene ring and the polyene side
chain of retinol and the amino acid residues lining the barrel of
plasma RBP are shown in Figure 2A. All of these amino acids are
highly conserved in RBP apart from Gln98, which changes to Glu
in Xenopus laevis. The interactions between RBP and retinol are
mainly hydrophobic, and except for the methyl groups of the
polyene side chain, the C19 and C20 atoms are relatively close to
polar groups. The hydroxyl group of the retinol side chain is
located at the entrance of the RBP barrel and its oxygen atom
participates in polar interactions with Q98 and water. The
structural comparison between the liganded and unliganded forms
of RBP did not reveal significant conformational changes. The
most significant difference between the two forms is a conforma-
tional change involving residues 34 to 37 [6].
In cellular retinol-binding proteins, the all-trans retinol has a
planar conformation in which the hydrogen atom of the hydroxyl
group bonds to the side chain of glutamine 108. This interaction
explains preference of CRBP for binding retinol rather than
retinal. The b-ionone ring at the entrance of the CRBP barrel is
surrounded by an amino acid side chain (Fig. 1C). For the most
part, the binding cavity conforms to the van der Waal’s surface of
the retinol. The only polar group found in retinol is the hydroxyl
end, which bonds with the side chain of Glu108 (Fig. 2B).
Four types of cellular retinol-binding protein (CRBP I, II, III,
and IV) with distinct tissue distributions and retinoid binding
properties have been structurally characterized so far [9,11].
Structural superimposition of these proteins demonstrated that the
retinol binding pocket residues are highly superimposable. Indeed,
the relative positions of the binding residues in the four types of
proteins are nearly same. Moreover, the residues lining the retinol
binding site are either identical or chemically conserved in CRBP
I, II, III and CRBP IV. The only exception is Q108 whose amide
group hydrogen bonds with the hydroxyl group of retinol in CRBP
I and most known CRBP II proteins. In chicken and xenopus
laevis CRBP II, amino acid 108 is mutated to histidine. The Q108
residue is replaced by histidine in CRBP III and CRBP IV (Fig.
S1). This result is consistent with Folli’s study on similarities of
ligand binding between CRBP I, II, and III [2]. The Q-H switch
at position 108 may have functional significance. In fact, H108
protonation might occur after the protein is exposed to a weakly
acidic microenvironment or as the consequence of protein
conformational change.
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ERABP and CRABPs
Although both proteins bind retinoic acid, the sequence and
structure of ERABP and CRABPs are significantly different (e.g.,
sequence identity=15.85%, Rmsd=3.2 A ˚) (Table S2 and S3).
Moreover, the binding sites for retinoic acid are at very different
positions (Fig. 1D). As the structure alignment shows, the retinoic
acid –COOH group is in an opposite orientation in the ERABP
and CRABP barrels. Although they both have polar sites for
binding the –COOH group, the binding sites have no conserved
amino acids. Furthermore, the conformation of retinoic acid is
changed in different binding proteins. In ERABP, the ligand is
clearly sickle shaped, and all-trans retinoic acid adopts an 8-cis
structure, where the C7–C8–C9–C10 torsion angle is equal to 0u
in the binding cavity [7]. However, in CRABP, the all-trans-
retinoic acid is nearly flat with the ionone ring showing a
significant deviation (233u) from the cis conformation [13].
The ligand binds deeply in the b-barrel of ERABP. The binding
site in ERABP is complementary to the amphipathic ligand in
both shape and chemical nature and largely excludes water in
contrast to what is described for the retinoic acid binding site of
the cellular retinoic acid binding protein [13]. There is a large
amphipathic cavity inside the b-barrel, which forms the binding
site and the binding site entrance (Fig. 3A). The charge network is
located at the carboxylate end of the retinoic acid binding site.
Three positively charged amino acids (Arg80, Lys85 and Lys115)
and two negatively charged amino acids (Glu17 and Glu63) along
with the retinoic acid carboxylate form a network of three paired
ions at the entrance end of the amphipathic binding site.
Additional polar side chains and water molecules also participate
in the network. In the interior, these side chains make van der
Figure 2. The retinol-binding cavity in RBP and CRBP. Ligand binding sites show as cartoon and transparent surface respectively. The binding
site surface is illustrated by meshed colors according to the electrostatic potential. We show the binding cavity in different directions to facilitate the
observation of the polar interaction between the retinol and the transport proteins. (A) The yellow dashed line is the polar interaction between the
retinol –OH and GLN98 in RBP. (B) The yellow dashed line is the polar interaction between the retinol –OH and GLN108 in CRBP. Water molecules (red
balls) adjacent to the retinol –OH form polar interactions between water molecules and other water molecules or side chain amino acids (left picture).
doi:10.1371/journal.pone.0036772.g002
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ionone ring. Sequence alignment shows that the amino acids
involved in ligand binding are conserved in ERABP, except that
Arg80 changes to Lys, which does not affect the protein-ligand
polar interaction.
Two forms of CRABP have been identified with distinct tissue
distributions and ligand specificities [2]. CRABP I appears to have
a somewhat higher binding affinity for RA than CRABP II does.
The amino acids in the binding sites of CRABP I and II are highly
conserved among different species, thus we chose CRABP II as a
case to analyze the ligand binding. CRABPs have extensive
interactions with retinoic acid. These residues are shown in
Figure 3B. The carboxylate of the ligand interacts with a trio of
residues (Arg132, Tyr134 and Arg111). Water molecules also
participate in the protein-ligand polar interaction network.
Conclusion
Current knowledge regarding the metabolism of naturally
occurring retinoids has been summarized in this paper. Dietary
provitamin A carotenoids are largely converted to retinol (vitamin
A) during intestinal absorption in mucosal cells. Newly absorbed
vitamin A is stored in the liver as retinol and then displays two
distinct functions through different conversion, which is essential
for vision when it is converted to retinal (retinaldehyde), as well as
participates in gene transcription when it is converted to retinoic
acid [19]. Retinoic acid can be produced in the body by two
Figure 3. The retinoic acid-binding cavity in ERABP and CRABP. The retinoic acid binding sites are displayed and colored as in Figure 2. (A) In
ERABP, three positively charged amino acids (Arg80, Lys85 and Lys115) along with the retinoic acid carboxylate form a network of three ion pairs at
the entrance end of the amphipathic binding site. Additional polar side chains and water molecules that participate in the network are included. (B)
The carboxylate of the ligand interacts with a trio of residues (Arg132, Tyr134 and Arg111) in CRABP.
doi:10.1371/journal.pone.0036772.g003
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further to retinoic acid, and this conversion is irreversible. All-trans
retinoic acids are synthesized enzymatically from all trans-retinals
and bind as ligand to the retinoic acid receptor family, which
regulates genes transcription [20]. Retinoic acid acts by binding to
the heterodimer of retinoic acid receptor (RAR) and the retinoid
X receptor (RXR), which then bind to retinoic acid response
elements (RAREs) in the regulatory regions of direct target genes
(including Hox genes), thereby activating gene transcription [21].
Vitamin A is mobilized from liver stores and transported in
plasma as retinol bound to a specific transport protein, called
retinol-binding protein (RBP), which delivers retinol to peripheral
target tissues. To specifically transport its ligand, RBP interacts
with a number of intermoleculars, such as RBP carrier protein,
TTR, to form a complex, which is proposed to be the vehicle for
specific interaction with a putative cell surface receptor that
mediates retinol uptake [22]. The existence of RBP receptor is
supported by a large body of evidences. The hypothesis that has
been advanced by Sundaram et al. [23] and other subsequent
reviews involves a high-affinity retinol binding form of RBP that
interacts with its receptor and releases retinol to the transport
mechanism [24]. Given the potent biological effects (e.g., toxicity)
of vitamin A and its derivatives, the controlled release of vitamin A
into cells from holo-RBP through receptors [25] has an
evolutionary advantage over the nonspecific diffusion of vitamin
A. This mechanism makes it possible to achieve high efficiency
and specificity for vitamin A delivery to organs distant from the
liver, such as the eye, the brain, the placenta, and the testis
[15,26].
The RBP receptor on the cell surface not only specifically binds
to RBP but also mediates vitamin A uptake from vitamin A-loaded
RBP (holo-RBP). In doing so, RBP assumes a lower affinity form,
which can readily be replaced on the receptor [15,26]. To test this
hypothesis, we performed molecular dynamics simulations to
calculate the binding energy using the Discovery studio client 2.5
with the CDOCKER [27] protocol. We obtained the ten lowest
energy conformations (Table S1). A significant rank sum test using
MATLAB results shows that the energy of CRBP binding retinol
(average of 281.24 kcal/mol) is lower than that of RBP (average
of 286.83 kcal/mol, p=1.83610
24). This is in disagreement with
Redondo and Vouropoulou’s assumption. Our dynamics simula-
tions also show that the average retinoic acid binding energies in
ERABP and CRASP are 2105.47 kcal/mol and 2226.28 kcal/
mol, respectively, which are higher than that of retinol
(p=1.83610
24). This may account for the polar interactions
between retinoic acid and transport proteins.
Considering these findings, we propose a possible model for
retinoid transport throughout the body (Fig. 4). In plasma, retinol
binds with RBP in a higher-affinity form. Some retinol is oxidized
to retinoic acid in the epididymis, which is required for sperm
maturation. Most of the retinol in plasma is transported to the
interior of target cells through acrossing the cell membrane via a
specific receptor. And then in cell, retinol is picked up by an
intracellular structural homolog, called cellular retinol-binding
protein (CRBP), in a lower-affinity form, which may facilitate its
Figure 4. The retinoid possible transport model. In plasma, retinol binds with RBP in a higher-affinity form. Some of the retinol is oxidized to
retinoic acid in the epididymis, which is required for sperm maturation. Most of the plasma retinol is transported to the interior of target cells across
and across the cell membrane by a specific receptor. The retinol is picked up from the membrane by an intracellular structural homolog, called
cellular retinol-binding protein (CRBP), in a lower-affinity form. Once inside the cells, the low affinity form may be readily used by the cell. In different
subcellular locations, the retinol binding orientation is reversed. When the body is in need of vitamin A, the retinol dissociates from the CRBP, whichi s
converted into retinoic acid and bound by CRABP. CRABP then transports retinoic acid to the nucleus across the nuclear receptor, thereby activating
gene transcription.
doi:10.1371/journal.pone.0036772.g004
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binding orientation is reversed. When the body is in need of
vitamin A, retinol dissociates from CRBPs and is converted into
retinoic acid and then bound by CRABP. CRABP then transports
retinoic acid to the nuclear receptors, thereby activating gene
transcription. This process involves many protein-protein interac-
tions, and conformational changes may be an integral part of the
retinoid transfer mechanism. Moreover, the dissociation of retinol
from CRBP appears to require the assistance of an external factor.
The targeted release of retinol in vivo is likely to be promoted by the
properties of the microenvironment near the membranes where
the enzyme molecules that are involved in its metabolism are
embedded. In conclusion, although the crystal and solution
structures, as well as the backbone dynamics of various intracel-
lular retinoid carriers in the apo- and holo-form provide
fundamental information, they do not lead to a common
mechanism of ligand exchange. In particular, the different levels
of accessibility to the cavity might be the result of fine tuning of the
protein conformation, which is made possible by the limited
differences between the sequences and is likely to be required to
optimize each carrier protein’s physiological function [10].
In the process of evolution, similar protein architectures can be
adapted to bind similar ligands in completely different ways [14].
Retinoid transport proteins are a good example of this principle.
In the same superfamily, RBP, ERABP, CRBPs and CRABPs may
descend from a common ancestor. Additionally, in different
locations within the cell their structure and binding mechanisms
have changed during evolution.
Materials and Methods
Date collection
We chose the PDB codes for 1BRP, 1EPB, 1CRB and 1CBS as
examples of the RBP, ERABP, CRBPs and CRABPs families of
proteins, respectively. The structures and sequences were retrieved
from the Protein Data Bank (PDB) [28]. We then used the four
stand-alone PSI-BLAST sequences [29] to search against the non-
redundant (NR) database (iteration=5, b=1000, others are
default) and retrieve the sequences. The binding site amino acids
were collected using the notation of the PDBsum database [30,31].
Sequence, structure alignment and binding amino acid
conservation analyses
The sequences of each transport protein were aligned by
CLUSTALW [32]. Pairwise protein structure alignments were
performed with the CE [33] program. The structure and binding
site analyses were performed with the Discovery studio client 2.5
program using standard parameters.
Molecular dynamics simulation and statistical analysis
Molecular dynamics (MD) simulations were performed using
CDOCKER [27], a CHARMm-based MD docking algorithm in
Discovery Studio (v2.5.0.9164), and the top 10 conformations for
every protein were used to calculate the binding energy.
To perform these docking studies, the four retinoid protein-
ligand complexes were collected from the PDB database (IDs are
1BRP, 1EPB, 1CRB and 1CBS). The protein is kept rigid while
the ligands are treated as fully flexible. Random conformations of
the ligands are generated using high-temperature MD. The
conformations are then translated into the binding site. Candidate
conformations are then created using random rigid-body rotations
followed by simulated annealing. A final minimization step is
applied to each of the ligand’s docking conformations by using a
CHARMm-based molecular dynamics (MD) scheme for 100
picoseconds. In this process, the heating target temperature was set
to 700 K, and the cooling target temperature was set to 300 K.
These minimized docking conformations were then clustered
based on a heavy atom RMSD approach using a 1.5 A ˚ tolerance.
The ranking of the ligand’s docking conformations was based on
the total docking energy (including the intermolecular energy for
ligands and the ligand-protein interactions). For every protein, the
top ten conformations were used to calculate the receptor-ligand
binding free energies.
A statistical significance analysis between the pairs of each
protein-ligand binding energy data was performed using a rank-
sum test in Matlab (version 7.13.0.564).
Supporting Information
Figure S1 Multiple sequence alignment of four types
CRBPs. Conserved amino acid residues are boxed in different
color by amino acid attribute. In four types CRBPs, the retinol
binding site residues are either identical or chemically conserved in
CRBP I, II and CRBP III and CRBP IV. The only exception is
Q108 (the star noted in picture), a residue whose amide group
hydrogen bonds the alcoholic group of retinol in CRBP I and most
CRBP II proteins. In chicken and xenopus laevis, CRBP II at
amino acid 108 was mutated to histidine. The Q108 residue is
replaced by histidine in CRBP III and CRBP IV.
(PDF)
Table S1 The binding energy between retinoids binding
proteins and their ligands.
(PDF)
Table S2 The sequence identity of four retinoids
binding proteins.
(PDF)
Table S3 The value of RMSD of CE structure alignment.
(PDF)
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